{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:38:28Z","timestamp":1788295108394,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaad.2023.04.069","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T11:25:21Z","timestamp":1686223521000},"page":"952-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A\u00a0small clinical trial"],"prefix":"10.1016","volume":"89","author":[{"given":"Cristian D.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarod John","family":"Pamatmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Burningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather W.","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2023.04.069_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.jaad.2023.04.069_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.jaad.2023.04.069_bib3","first-page":"831","article-title":"Small mouths ... big problems? A review of scleroderma and its oral health implications","volume":"73","author":"Albilia","year":"2007","journal-title":"J Can Dent Assoc"},{"issue":"9","key":"10.1016\/j.jaad.2023.04.069_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jop.12739","article-title":"Impact of systemic sclerosis oral manifestations on patients\u2019 health-related quality of life: a systematic review","volume":"47","author":"Smirani","year":"2018","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"10.1016\/j.jaad.2023.04.069_bib5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jaad.2023.04.069_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13075-019-2062-0","article-title":"Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study","volume":"21","author":"Pirrello","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.jaad.2023.04.069_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jdcr.2019.08.004","article-title":"Hyaluronidase injections for treatment of symptomatic pansclerotic morphea-induced microstomia","volume":"5","author":"Abbas","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"7","key":"10.1016\/j.jaad.2023.04.069_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jamadermatol.2019.0585","article-title":"Hyaluronidase treatment of scleroderma-induced microstomia","volume":"155","author":"Melvin","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.069_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006534-199404001-00003","article-title":"Aesthetic indications for botulinum toxin injection","volume":"93","author":"Guyuron","year":"1994","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.069_bib11","doi-asserted-by":"crossref","first-page":"821e","DOI":"10.1097\/PRS.0000000000002625","article-title":"Effect of botulinum toxin type A on TGF-\u03b2\/Smad pathway signaling: implications for silicone-induced capsule formation","volume":"138","author":"Kim","year":"2016","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.jaad.2023.04.069_bib12","doi-asserted-by":"crossref","first-page":"171e","DOI":"10.1097\/PRS.0000000000001438","article-title":"Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue","volume":"136","author":"Jeong","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"3 Pt 2","key":"10.1016\/j.jaad.2023.04.069_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/dsu.12148","volume":"39","author":"Carruthers","year":"2013","journal-title":"Dermatol Surg"},{"issue":"19","key":"10.1016\/j.jaad.2023.04.069_bib14","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jaad.2023.04.069_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10787-010-0069-x","article-title":"The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis","volume":"19","author":"Zhang","year":"2011","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.069_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dsu.12463","article-title":"Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies","volume":"40","author":"Cavallini","year":"2014","journal-title":"Dermatol Surg"},{"issue":"9","key":"10.1016\/j.jaad.2023.04.069_bib17","first-page":"943","article-title":"Botulinum toxin in the long-term treatment of refractory Raynaud\u2019s phenomenon","volume":"18","author":"Asad","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2023.04.069_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219348","article-title":"The novel use of botulinum toxin A for the treatment of Raynaud\u2019s phenomenon in the toes","volume":"2018","author":"Dhaliwal","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.jaad.2023.04.069_bib19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.40123","article-title":"The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud\u2019s phenomenon: A randomized, double-blind, placebo-controlled clinical trial","volume":"69","author":"Bello","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.04.069_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1346-8138.13030","article-title":"Beneficial effect of botulinum toxin A on Raynaud\u2019s phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study","volume":"43","author":"Motegi","year":"2016","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.04.069_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaad.2017.07.006","article-title":"A novel treatment for limited mouth opening due to facial fibrosis: a case series","volume":"78","author":"Hoverson","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2023.04.069_bib23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/ard.2007.070532","article-title":"Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale","volume":"66","author":"Mouthon","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaad.2023.04.069_bib24","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.jaad.2023.04.069_bib25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.069_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0030-4220(84)90309-8","article-title":"The nonsurgical treatment of microstomia in scleroderma: a pilot study","volume":"57","author":"Naylor","year":"1984","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.069_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1034\/j.1601-0825.2003.03971.x","article-title":"Oral lesions in recessive dystrophic epidermolysis bullosa","volume":"9","author":"Serrano-Mart\u00ednez","year":"2003","journal-title":"Oral Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223010198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223010198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:28:11Z","timestamp":1759274891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223010198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0190962223010198"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.04.069","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A\u00a0small clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.04.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}